EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis

Fadi Kharouf, Aiman Arraf, Vinod Chandran

Expert Review of Clinical Pharmacology · 04.05.2026 · 19 (5) · 457-470

DOI: 10.1080/17512433.2026.2667340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 03.05.2026. Verfasst von Fadi Kharouf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Antirheumatic Agents. Die Arbeit nennt 142 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Achieving sustained remission in psoriatic arthritis (PsA) remains challenging despite the availability of multiple biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs). Heterogeneous disease expression, comorbidities, and variable durability of response limit treatment effectiveness. AREAS COVERED: This review summarizes contemporary and emerging pharmacologic approaches to PsA, spanning established therapies targeting tumor necrosis factor (TNF), the interleukin-23/interleukin-17 (IL-23/IL-17) axis, and Janus kinase (JAK) signaling, as well as emerging strategies such as selective tyrosine kinase 2 (TYK2) inhibition, dual JAK1/TYK2 inhibition, oral interleukin-23 receptor-targeted peptides, and novel biologic platforms. A structured literature search of PubMed, MEDLINE, and ClinicalTrials.gov was conducted for studies published between January 2000 and April 2026. Evidence from randomized controlled trials, long-term extension studies, and real-world observational cohorts informed assessment of efficacy, durability, safety, treatment sequencing, and drug survival, with emphasis on multidomain involvement and metabolic and non-inflammatory drivers of disease activity. EXPERT OPINION: Progress in PsA management will depend less on expanding therapeutic options and more on improving sustained remission rates. Phenotype- and mechanism-informed treatment selection, proactive treat-to-target implementation, and systematic reassessment of residual inflammatory versus non-inflammatory disease activity are central to optimizing long-term outcomes. Emerging therapies may refine existing strategies by improving durability and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticAntirheumatic AgentsHumansRemission InductionMolecular Targeted TherapyTreatment OutcomeAnimalsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

B/tsDMARDSPsoriatic arthritisprecision medicineremissiontreatment strategies

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Rheumatology Unit, Department of Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada.
  • B. Shine Department of Rheumatology, Rambam Medical Center, Haifa, Israel.
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Zitieren

APA

Kharouf, F., Arraf, A., & Chandran, V. (2026). Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis. Expert Review of Clinical Pharmacology, 19(5), 457-470. https://doi.org/10.1080/17512433.2026.2667340

Vancouver

Kharouf F, Arraf A, Chandran V. Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis. Expert Review of Clinical Pharmacology. 2026;19(5):457-470. doi:10.1080/17512433.2026.2667340

BibTeX
@article{Kharouf2026,
  author = {Kharouf, Fadi and Arraf, Aiman and Chandran, Vinod},
  title = {Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {457--470},
  doi = {10.1080/17512433.2026.2667340}
}
Kostenlos starten →